Johnson & Johnson on Pace for Largest Percent Decrease Since May 2025 — Data Talk
Johnson & Johnson (JNJ) is currently at $228.32, down $5.88 or 2.51%
--Would be lowest close since June 4, 2026, when it closed at $228.17
--On pace for largest percent decrease since May 13, 2025, when it fell 3.7%
--Currently down five of the past six days
--Currently down four consecutive days; down 5.21% over this period
--Longest losing streak since June 2, 2026, when it fell for four straight trading days
--Worst four day stretch since the four days ending April 21, 2026, when it fell 5.24%
--Down 5.21% this week; worst weekly performance since the week ending April 4, 2025, when it fell 6.40%
--Up 1.32% month-to-date
--Up 10.32% year-to-date
--Down 8.14% from its all-time closing high of $248.56 on March 2, 2026
--Up 51.47% from 52 weeks ago (June 18, 2025), when it closed at $150.73
--Down 8.14% from its 52-week closing high of $248.56 on March 2, 2026
--Up 52.42% from its 52-week closing low of $149.79 on June 20, 2025
--Traded as low as $228.11; lowest intraday level since June 4, 2026, when it hit $225.90
--Down 2.6% at today's intraday low
--Third worst performer in the DJIA today
--Subtracted 36.23 points from the DJIA so far today
All data as of 11:02:41 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 18, 2026 11:21 ET (15:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
The Thrilling 37
3 Stocks to Invest In With More Room to Run
